Amber E. de Groot
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
- Pancreatic and Hepatic Oncology Research
- Immunology top 10%
- Immune cells in cancer
Papers in
-
- Immune cells in cancer 5
- Phagocytosis and Immune Regulation 1
- Oncology 3
- Cancer Cells and Metastasis 2
- Cancer Immunotherapy and Biomarkers 1
- Co-authors
- Kenneth J. Pienta (6 shared papers)Kenneth C. Valkenburg (1 shared paper)Peter V. Robinson (2 shared papers)Carolyn Ruth Bertozzi (2 shared papers)Julia L. McKechnie (2 shared papers)Sarah R. Amend (4 shared papers)Joel S. Brown (1 shared paper)Cheng‐ting Tsai (1 shared paper)
- Journals
- Journal of the American Chemical Society (2 papers)Medical Oncology (1 paper)Science Translational Medicine (1 paper)Oncotarget (1 paper)Neoplasia (1 paper)
- Partner nations
- United States
In The Last Decade
Amber E. de Groot
10 papers receiving 1.6k citations
Amber E. de Groot's Hit Papers
Peers
Comparison fields: 5 of 78
- Oncology 505
- Immunology 308
- Biomaterials 132
- Cancer Research 112
- Molecular Biology 376
Countries citing papers authored by Amber E. de Groot
This map shows the geographic impact of Amber E. de Groot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amber E. de Groot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amber E. de Groot more than expected).
Fields of papers citing papers by Amber E. de Groot
This network shows the impact of papers produced by Amber E. de Groot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amber E. de Groot. The network helps show where Amber E. de Groot may publish in the future.
Co-authors
The 24 scholars most cited alongside Amber E. de Groot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Targeting the tumour stroma to improve cancer therapy Hit paper breakdown → | 2018 | 888 |
| 2 | 2020 | 325 | |
| 3 | 2018 | 88 | |
| 4 | 2017 | 82 | |
| 5 | 2015 | 80 | |
| 6 | 2016 | 56 | |
| 7 | 2022 | 24 | |
| 8 | 2024 | 17 | |
| 9 | 2021 | 16 | |
| 10 | 2023 | 12 |
About Amber E. de Groot
Amber E. de Groot is a scholar working on Immunology, Oncology, Molecular Biology, Pulmonary and Respiratory Medicine and Organic Chemistry, having authored 10 papers that have together received 1.6k indexed citations. Recurring topics across this work include Immune cells in cancer (5 papers), Glycosylation and Glycoproteins Research (2 papers), Cancer Cells and Metastasis (2 papers), Cancer Immunotherapy and Biomarkers (1 paper), Phagocytosis and Immune Regulation (1 paper), Prostate Cancer Treatment and Research (1 paper) and Click Chemistry and Applications (1 paper). The work is most often cited by research in Oncology (505 citations), Immunology (308 citations), Biomaterials (132 citations), Cancer Research (112 citations) and Molecular Biology (376 citations). Amber E. de Groot has collaborated with scholars based in United States. Frequent co-authors include Kenneth J. Pienta, Kenneth C. Valkenburg, Peter V. Robinson, Carolyn Ruth Bertozzi, Julia L. McKechnie, Sarah R. Amend, Joel S. Brown, Cheng‐ting Tsai, Kayla V. Myers and William Nathaniel Brennen. Their work appears in journals such as Journal of the American Chemical Society, Medical Oncology, Science Translational Medicine, Oncotarget and Neoplasia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.